More From The Market Online
ResMed spikes on robust results and global growth spurt
ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.
- Keely Lynch
- 1 min
- 26 April 2024 13:45 (AEST)
PharmAust CEO’s sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…
- Keely Lynch
- 1 min
- 23 April 2024 12:08 (AEST)
Recce wins safety board approval to dose 4g in R327 UTI infusion trial
Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…
- Jonathon Davidson
- 2 mins
- 26 April 2024 10:39 (AEST)
Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M
WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…
- Jonathon Davidson
- 2 mins
- 23 April 2024 12:42 (AEST)